To assess the in vivo anti‐leukemia effect of Baicalein in human primary AML cells, we established two primary AML cells‐bearing mice models engrafted by primary AML cells (#29) with t(8;21)q(22;22) and #39, a non‐CBF‐AML sample respectively. Here, CEBPZ is linked to leukemia.